These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Binding of 125I-iodohydroxybenzylpindolol to cerebral membranes: association with 5-hydroxytryptamine recognition sites as well as beta-adrenoceptors.
    Author: Willcocks AL, Nahorski SR.
    Journal: Biochem Pharmacol; 1983 Nov 15; 32(22):3311-9. PubMed ID: 6316978.
    Abstract:
    The binding characteristics of the radio-iodinated beta-adrenoceptor antagonist ligand 125I-iodohydroxybenzylpindolol (125I-IHYP) have been compared in membrane preparations derived from three different sources in a single mammalian species. In membrane preparations derived from rat lung and erythrocytes, 125I-IHYP binds solely to beta-adrenoceptors as defined by the stereoselectivity of the isomers of propranolol and the affinity of isoprenaline. However, in membranes prepared from rat cerebral cortex, although some 30% of 125I-HYP binding is to beta-adrenoceptors, a large proportion of the remainder is to sites that exhibit characteristics for 5-hydroxytryptamine (5HT) recognition. Thus, binding assays for 125I-IHYP in cerebral cortical membranes performed in the presence of 30 microM (-)-isoprenaline (to eliminate the binding of the ligand to beta-adrenoceptors) show that isomers of propranolol still maintain a degree of stereoselectivity at these sites. Also, 5HT and its congeners exhibit binding activity similar to that seen at 5HT receptors identified by 3H-5HT.
    [Abstract] [Full Text] [Related] [New Search]